… of pituitary carcinomas and aggressive pituitary adenomas. Here, … and results of temozolomide
therapy in pituitary tumors, as … temozolomide treatment, duration of therapy, dosage, tumor …

… After temozolomide failure, no evidence-based treatment … pituitary tumors (APTs) and
pituitary carcinomas (PCs). Moreover, once temozolomide has failed, the survival of these patients …

… correlates with response to temozolomide chemotherapy. Herein, … pituitary tumors, indolent,
aggressive and malignant. A literature review of the use of temozolomide in pituitary tumors …

… six patients with aggressive pituitary tumors. Three patients, one with a lactotroph adenoma
… be useful to treat patients with highly aggressive, refractory pituitary tumors who failed to …

A subset of pituitary neuroendocrine tumors (PitNETs) have … To date, for aggressive PitNETs,
temozolomide (TMZ) has … However, given the fact that roughly only one third of patients …

… patients with an objective response to temozolomide, tumor … 15 patients with aggressive
pituitary tumors and pituitary carcinomas … to non-metastatic pituitary tumors may respond more …

… pituitary adenoma cellular responses to temozolomide. We look forward to further investigation
of the effects of temozolomide in challenging cohorts of pituitary adenoma patients and in …

… , such as temozolomide, have been used in few cases of pediatric pituitary tumors with …
However, standard surgical treatment and temozolomide seem to be safe and well tolerated …

… The failure of temozolomide here was expected given the lack of a functional mismatch
repair complex, and one must wonder whether the many treatment failures seen when that drug …

… previously operated or irradiated invasive adenomas. In vivo models predict … in pituitary
tumour initiation, progression and metastatic potential. Analysis of many both pituitary adenomas …